These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 26934023)

  • 1. Drug-Induced Long-QT and Torsades de Pointes in Elderly Polymedicated Patients.
    García-Fuertes D; Villanueva-Fernández E; Crespín-Crespín M
    Arq Bras Cardiol; 2016 Feb; 106(2):156-9. PubMed ID: 26934023
    [No Abstract]   [Full Text] [Related]  

  • 2. Methadone-induced long QT syndrome vs methadone-induced torsades de pointes.
    Justo D
    Arch Intern Med; 2006 Nov; 166(20):2288; author reply 2289-90. PubMed ID: 17101953
    [No Abstract]   [Full Text] [Related]  

  • 3. Female gender does not influence the magnitude of ibutilide-induced repolarization delay and incidence of torsades de pointes in an in vivo rabbit model of the acquired long QT syndrome.
    Johansson M; Carlsson L
    J Cardiovasc Pharmacol Ther; 2001 Jul; 6(3):247-54. PubMed ID: 11584331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-induced prolongation of the QT interval.
    Roden DM
    N Engl J Med; 2004 Mar; 350(10):1013-22. PubMed ID: 14999113
    [No Abstract]   [Full Text] [Related]  

  • 5. QT prolongation and Torsades de Pointes in patients previously treated with anthracyclines.
    Arbel Y; Swartzon M; Justo D
    Anticancer Drugs; 2007 Apr; 18(4):493-8. PubMed ID: 17351403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early afterdepolarizationlike activity in patients with class IA induced long QT syndrome and torsades de pointes.
    Kurita T; Ohe T; Shimizu W; Suyama K; Aihara N; Takaki H; Kamakura S; Shimomura K
    Pacing Clin Electrophysiol; 1997 Mar; 20(3 Pt 1):695-705. PubMed ID: 9080496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The risk for Torsades de Pointes and polypharmacy in schizophrenia.
    Tirupati S
    Schizophr Res; 2021 Feb; 228():239-240. PubMed ID: 33482609
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug-induced long QT syndrome and Torsade de Pointes.
    Chism S; Smith E
    J Ark Med Soc; 2004 Jul; 101(1):24-6. PubMed ID: 15270138
    [No Abstract]   [Full Text] [Related]  

  • 9. Prolonged QT: A rare cause of cardiac arrest.
    Carlquist J
    JAAPA; 2015 Aug; 28(8):. PubMed ID: 26208008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Citalopram induced torsade de pointes, a rare life threatening side effect.
    Kanjanauthai S; Kanluen T; Chareonthaitawee P
    Int J Cardiol; 2008 Dec; 131(1):e33-4. PubMed ID: 17919753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QT prolongation and Torsades de Pointes following overdose of ziprasidone and amantadine.
    Manini AF; Raspberry D; Hoffman RS; Nelson LS
    J Med Toxicol; 2007 Dec; 3(4):178-81. PubMed ID: 18072173
    [No Abstract]   [Full Text] [Related]  

  • 12. High prevalence of risk factors in elderly patients using drugs associated with acquired torsades de pointes chronically in Colombia.
    Moreno-Gutiérrez PA; Gaviria-Mendoza A; Cañón MM; Machado-Alba JE
    Br J Clin Pharmacol; 2016 Aug; 82(2):504-11. PubMed ID: 27060989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding drug-induced torsades de pointes: a genetic stance.
    Kannankeril PJ
    Expert Opin Drug Saf; 2008 May; 7(3):231-9. PubMed ID: 18462182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Warning to "Refeeding syndrome". Torsades de pointes and ventricular tachyarrhythmia with marked QT prolongation induced by acute glucose injection: report of two cases.
    Inoue T; Doi T; Beppu K; Sasaki Y; Takeda S; Watanabe C; Shirasaka A; Kakio T; Hashimoto T; Kawai C; Kida Y; Nishina N; Esato M
    Int J Cardiol; 2012 Apr; 156(2):222-4. PubMed ID: 22341754
    [No Abstract]   [Full Text] [Related]  

  • 15. A Case of Nonfatal Torsade de Pointes Associated With Psychiatric Polypharmacy.
    Lister JF; Torbett AL; Benge CD; Bean JR
    J Clin Psychopharmacol; 2018 Apr; 38(2):155-157. PubMed ID: 29424801
    [No Abstract]   [Full Text] [Related]  

  • 16. Torsades de pointes associated with acquired long QT syndrome: observation of 7 cases.
    Takahashi N; Ito M; Inoue T; Koumatsu K; Takeshita Y; Tsumabuki S; Tamura M; Inoue K; Maeda T; Saikawa T
    J Cardiol; 1993; 23(1):99-106. PubMed ID: 8164140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant use of levofloxacin and fluconazole leading to possible torsades de pointes.
    Tilton JJ; Sadr R; Groo VL
    J Oncol Pharm Pract; 2019 Dec; 25(8):2004-2006. PubMed ID: 30501378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards a drug concentration effect relationship for QT prolongation and torsades de pointes.
    Webster R; Leishman D; Walker D
    Curr Opin Drug Discov Devel; 2002 Jan; 5(1):116-26. PubMed ID: 11865665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug-induced long QT syndrome and torsade de pointes arrhythmias].
    Dhein S
    Dtsch Med Wochenschr; 2000 Jun; 125(22):703-8. PubMed ID: 10874898
    [No Abstract]   [Full Text] [Related]  

  • 20. [Torsades de pointes ventricular tachycardia caused by terodiline (Mictrol)?].
    Pedersen JL; Ohmsen E
    Ugeskr Laeger; 1992 Sep; 154(40):2760-1. PubMed ID: 1413214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.